Doaa Elnagar

Dr. Doaa Elnagar


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 June 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
WAWael Alanazi
Wael Alanazi
TATurki Alharbi
Turki Alharbi
DEDoaa Elnagar
Doaa Elnagar
AAAbdullah M. Albogami
Abdullah M. Albogami
MAMohammed AlSwayyed
Mohammed AlSwayyed
Sodium-glucose cotransporter-2 (SGLT2) inhibitors have been suggested to have anti-inflammatory properties in diabetes. The goal of this study was to evaluate the role of the SGLT2 inhibitor dapagliflozin (DAPA) in the attenuation of lipopolysaccharide (LPS)-induced hypotension. Male Wistar albino rats were divided into normal and diabetic groups and received DAPA (1 mg/kg/day) for two weeks followed by a single dose of 10 mg/kg LPS. Blood pressure was recorded throughout the study and the circulatory levels of cytokines were assessed using a multiplex array, while the aortas were harvested for analysis. DAPA attenuated the vasodilation and hypotension caused by LPS. Mean arterial pressure (MAP) was preserved in the normal and diabetic DAPA-treated septic groups (MAP = 83.17 ± 5.27, 98.43 ± 5.57 mmHg) compared to the vehicle-treated septic groups (MAP = 65.60 ± 3.31, 68.21 ± 5.88 mmHg). Most of the cytokines induced by LPS were decreased in the DAPA-treated septic groups. In the aorta, the inducible nitric oxide synthase-derived nitric oxide had lower expression in the DAPA-treated rats. In contrast, the expression of α-smooth muscle actin, a marker of the vessel’s contractile state, was higher in the DAPA-treated rats in comparison with non-treated septic rats. These findings revealed that the protective role of DAPA against LPS-induced hypotension is likely to be glucose-lowering independent, as was observed in the non-diabetic septic group. Taken together, the results show that DAPA has a potential effect in the prevention of the hemodynamic disturbances of sepsis regardless of glycemia levels.

14 February 2023 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
WAWael Alanazi
Wael Alanazi
AAAbdulrahman S. Alanazi
Abdulrahman S. Alanazi
DEDoaa Elnagar
Doaa Elnagar
AAAbdullah M. Aljuraybah
Abdullah M. Aljuraybah
Sary AlsaneaSary Alsanea
Sary Alsanea
MAMetab Alharbi
Metab Alharbi
Tivozanib is a triple vascular endothelial growth factor receptor inhibitor, recently approved for the treatment of refractory advanced renal cell carcinoma. Clinical studies showed that around 46% of patients who received tivozanib suffer from hypertension in all grades. Thus, the present study was conducted to identify the role of angiotensin-II (AngII) in the mechanism underlying tivozanib-induced vascular toxicity and hypertension. C57BL/6 male mice received tivozanib (1 mg/kg) with or without losartan (10 or 30 mg/kg) for 3 weeks. Blood pressure was recorded every 3 days, and proteinuria was measured every week. On day 21, all mice were euthanized, and samples were harvested for further analysis. Tivozanib elevated blood pressure until systolic blood pressure reached 163 ± 6.6 mmHg on day 21 of treatment with low urination and high proteinuria. AngII and its receptors, endothelin-1, and oxidative stress markers were significantly increased. While nitric oxide (NO) levels were reduced in plasma and aortic tissues. AngII type 1 receptor blockade by losartan prevented these consequences caused by tivozanib and kept blood pressure within normal range. The results showed that AngII and ET-1 might be potential targets in the clinical studies and management of hypertension induced by tivozanib.

Verified
Journal Article
Open access
PDF file
AAASMA S. ALONAZI
ASMA S. ALONAZI
ADAnfal Bin Dayel
Anfal Bin Dayel
BABashayer Ali Alkhathlan
Bashayer Ali Alkhathlan
LALulu Alkaff
Lulu Alkaff
AAAhad T. Alrashed
Ahad T. Alrashed
NANouf Mohammed Alrasheed
Nouf Mohammed Alrasheed
Myocardial infarction (MI) is a pathological condition associated with various cardiovascular diseases and leads to heart failure. Nuclear factor-kappa B (NF-κB) is upregulated in the infarcted heart. G protein-coupled receptor kinase 5 (GRK5) also plays a complex role in both tissue repair and maladaptive hypertrophy in cardiovascular diseases; however, its effect on NF-κB-mediated inflammation has not yet been elucidated. Thus, this study aims to investigate the effects of Amlexanox (AMX), a potential GRK5 inhibitor, in an animal model of MI by assessing its impact on GRK5-mediated NF-κB/inflammatory processes. Thirty-two male mice were randomly allocated into four groups: control, MI, (MI treated with vehicle (MI + V), and MI + AMX (AMX: 2.5 mg/100 g/day). MI was induced using ISO on days 21 and 22. The cardioprotective impacts of Amlexanox were verified by evaluating cardiac injury, inflammatory biomarker concentrations, and histopathological alterations in cardiomyocytes. MI induction was confirmed by increases in heart weight/body weight ratio (HW/BW) (p < 0.001), troponin (p < 0.001), creatine kinase (p < 0.001), and LDH (p < 0.001). Treatment with AMX resulted in a significant reduction in cardiac injury biomarkers (p < 0.001) and IL-6 (p < 0.05). The protein level of NF-κB(p65) and NF-κB(p105) was significantly increased in cardiac myocytes of the MI group. Treatment with AMX led to a significant decrease in NF-κB(p65) and (p105) expression (p < 0.01 and p < 0.001, respectively), and GRK5 and MEF2α protein levels were also upregulated. In conclusion, AMX shows potential cardioprotective effects by modulating the GRK5/MEF2-mediated NF-κB inflammatory signaling pathway.

11 September 2025 in Indian Journal of Animal Research
Verified
Journal Article
Open access
PDF file
NANouf A. Al-Ghamdi
Nouf A. Al-Ghamdi
SOSawsan A Omer
Sawsan A Omer
STSeham Al Terary
Seham Al Terary
MEMaha El-Tohamy
Maha El-Tohamy
PVPromy Virk
Promy Virk
Osama MohammedOsama Mohammed
Osama Mohammed
Background: Fruits of Citrullus colocynthis were collected from the central (Riyadh) and the northern (Hail) regions of Saudi Arabia. The total phenolic and flavonoid concentrations of the pulp extract from both regions were determined. The hepatorenal toxicity and the associated hematologic and biochemical changes in male Wistar rats were evaluated in experimental animals. Methods: Forty male Wistar rats were assigned to five equal groups. Group 1 as control and fed normal saline. Group 2 and 4 were fed 100 and 300 mg/kg bodyweight of C. colocynthis pulp extract from the central region respectively. Group 3 and 5 were fed 100 and 300 mg/kg bodyweight of C. colocynthis pulp extract from the northern region respectively. Result: The total phenolic and flavonoids contents of the pulp extract from the central and the northern regions were determined. There was a significant increase (p less than 0.05) in the total leucocytes counts in animals fed high doses of C. colocynthis pulp extract from both regions. The total platelets count was significantly increased (p less than 0.05) in groups 4 and 5. There was a significant increase in the serum concentrations of alkaline phosphatase and alanine aminotransferase. No significant increase in the levels of blood urea nitrogen and creatinine. Histologically, livers of the experimental animals showed dilatation of central veins, congestion of sinusoids, cytoplasmic degeneration of hepatocytes and infiltration of inflammatory cells. Kidneys showed dilatation of the glomeruli, severe congestion of kidney tissue with infiltration of inflammatory cells. Histological changes were dependent on the dose.